Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02208310 · ClinicalTrials.gov registry record · Phase 4
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Phase 4 study, sponsored by University of Michigan.
- Terminated
- Registry status
- Phase 4
- Development phase
- 11
- Enrollment target
NCT02208310 is a Phase 4 study that was terminated before completion, run by University of Michigan. The registered enrollment target is 11 participants.
The verdict
NCT02208310, a Phase 4 study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 11 participants
- Enrollment target
Study Summary
Crohn's disease is more common in areas of the world with less sunlight exposure. Sunlight is a major source of vitamin D. There is some research to suggest that patient's with higher vitamin D levels are less likely to undergo surgeries and have better control of their disease. We intend to study the effects of high dose vitamin D supplementation in patients with vitamin D deficiency and Crohn's disease. We hypothesize that patients given high doses will have less hospitalizations, surgeries, steroid use.
Interventions
- DRUG Cholecalciferol 10,000 IU
- DRUG Cholecalciferol 400 IU
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02208310
The ClinicalTrials.gov registry entry for NCT02208310 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cholecalciferol 10,000 IU is the first listed.
NCT02208310 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02208310 about?
NCT02208310 is a clinical study titled "Trial of High Dose Vitamin D in Patient's With Crohn's Disease". Crohn's disease is more common in areas of the world with less sunlight exposure. Sunlight is a major source of vitamin D. There is some research to suggest that patient's with higher vitamin D levels are less likely to undergo surgeries and have better control of their disease. We intend to study t...
What is the current status of trial NCT02208310?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 11 participants. The study started on 2015-04. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02208310?
The interventions under investigation include: Cholecalciferol 10,000 IU (DRUG), Cholecalciferol 400 IU (DRUG).
Who is sponsoring clinical trial NCT02208310?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.